Biotech Values

[iwfal]

If any product akin to what PP trumpets to investors on its conference calls ever comes to fruition, it will be in spite of what PP is doing, not because of it.

Take the wager or not?

BTW - On balance you are probably right that they are more hinderence than help to any worthy items in their pipeline at this point. Locking up the rights while not effectively moving the ball forward for the good items. But none of that was my point - my point was that they are a nexus for some interesting items. To condemn their entire pipeline as garbage because they are ineptly managed is overkill in my opinion.

Note that I watch other companies with potentially interesting products that are having significant problems - e.g. AGIX's 1067 is undoubtedly efficacious as a diabetes drug and the recent FDA moves actually improve its chances. Still not anywhere I would want to invest - but interesting to watch and, heck, something may happen to make it investable (not at all likely - but possible).